IL1RAPL2 | Interleukin 1 receptor accessory protein-like 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
IL23R | Interleukin 23 receptor | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
INSM1 | Insulinoma-associated 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
KCNA4 | Potassium voltage-gated channel, shaker-related subfamily, member 4 | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNG3 | Potassium voltage-gated channel, subfamily G, member 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH5 | Potassium voltage-gated channel, subfamily H (eag-related), member 5 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK3 | Potassium channel, subfamily K, member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNN2 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KLHL4 | Kelch-like family member 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LONRF2 | LON peptidase N-terminal domain and ring finger 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LRRN3 | Leucine rich repeat neuronal 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MAB21L1 | Mab-21-like 1 (C. elegans) | Predicted intracellular proteins
| | | | | Tissue enhanced |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MCF2 | MCF.2 cell line derived transforming sequence | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MERTK | MER proto-oncogene, tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MYO7A | Myosin VIIA | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NCBP2L | Nuclear cap binding protein subunit 2-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
NGB | Neuroglobin | Predicted intracellular proteins
| | | | | Tissue enhanced |
NGEF | Neuronal guanine nucleotide exchange factor | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | | | | Tissue enhanced |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | Cancer-related genes Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NUP62CL | Nucleoporin 62kDa C-terminal like | Predicted intracellular proteins
| | | | | Tissue enhanced |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PCDH15 | Protocadherin-related 15 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
PCSK2 | Proprotein convertase subtilisin/kexin type 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PIRT | Phosphoinositide-interacting regulator of transient receptor potential channels | Predicted membrane proteins
| | | | | Tissue enhanced |
PNMAL2 | Paraneoplastic Ma antigen family-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PORCN | Porcupine homolog (Drosophila) | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
PPM1E | Protein phosphatase, Mg2+/Mn2+ dependent, 1E | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PRPH | Peripherin | Predicted intracellular proteins
| | | | | Tissue enhanced |
QPCT | Glutaminyl-peptide cyclotransferase | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAET1G | Retinoic acid early transcript 1G | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RARRES2 | Retinoic acid receptor responder (tazarotene induced) 2 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RFX6 | Regulatory factor X, 6 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RGS7 | Regulator of G-protein signaling 7 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
RIMBP2 | RIMS binding protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RTBDN | Retbindin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RUNDC3B | RUN domain containing 3B | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCD5 | Stearoyl-CoA desaturase 5 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
SCG5 | Secretogranin V (7B2 protein) | Predicted secreted proteins
| | | | | Tissue enhanced |
SEPT4 | Septin 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
SHH | Sonic hedgehog | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |